Tech Company Financing Transactions

Tvardi Therapeutics Funding Round

683 Capital, ArrowMark Partners and Palkon Capital Management participated in a $74 million Series B venture round for Tvardi Therapeutics. This venture round was announced on 6/24/2021.

Transaction Overview

Announced On
6/24/2021
Transaction Type
Venture Equity
Amount
$74,000,000
Round
Series B
Investors

683 Capital (Lead Investor)

ArrowMark Partners (Lead Investor)

Palkon Capital Management (Lead Investor)

Slate Path Capital (Lead Investor) (Jamie McNab)

Sporos Bioventures

Proceeds Purpose
The company intends to use the funds to advance its product candidates through multiple clinical data readouts in mid-stage trials for cancer and fibrosis.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2450 Holcombe Blvd. X
Houston, TX 77021
USA
Email Address
Not Recorded
Overview
Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. Founded in 2017 and based in Houston, Texas, the company is led by experienced entrepreneurs, innovative scientists and dedicated physicians.
Profile
Tvardi Therapeutics LinkedIn Company Profile
Social Media
Tvardi Therapeutics Company Twitter Account
Company News
Tvardi Therapeutics News
Facebook
Tvardi Therapeutics on Facebook
YouTube
Tvardi Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Imran Alibhai
  Imran Alibhai LinkedIn Profile  Imran Alibhai Twitter Account  Imran Alibhai News  Imran Alibhai on Facebook
Chief Scientific Officer
Jeno Gyuris
  Jeno Gyuris LinkedIn Profile  Jeno Gyuris Twitter Account  Jeno Gyuris News  Jeno Gyuris on Facebook
VP - Bus. Development
Sofia de Achaval
  Sofia de Achaval LinkedIn Profile  Sofia de Achaval Twitter Account  Sofia de Achaval News  Sofia de Achaval on Facebook
VP - R & D
Jeffrey Larson
  Jeffrey Larson LinkedIn Profile  Jeffrey Larson Twitter Account  Jeffrey Larson News  Jeffrey Larson on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/24/2021: Lender Compliance Technologies venture capital transaction
Next: 6/24/2021: Lower venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on tech company VC transactions. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary